Home > Keywords > 
Catalog name Description price
R-R-2436 AU-15330 CAS No.2380274-50-8 AU-15330/CAS No.2380274-50-8 is a proteolysis-targeting chimera (PROTAC) degrader of the SWI/SNF ATPase subunits, SMARCA2 and SMARCA4. AU-15330 induces potent inhibition of tumour growth in xenograft models of prostate cancer and synergizes with the AR antagonist enzalutamide. AU-15330 induces disease remission in castration-resistant prostate cancer (CRPC) models without toxicity. price>
R-C-737 FLI-06 CAS No. 313967-18-9 FLI-06 is a Notch inhibitor and the early secretory pathway inhibitor.FLI-06 disrupts the Golgi apparatus in a manner distinct from that of brefeldin A and golgicide A. price>
R-R-2437 I-BET151 CAS No.1300031-49-5 I-BET151 (GSK1210151A)/CAS No.1300031-49-5 is a BET bromodomain inhibitor which inhibits BRD4, BRD2, and BRD3 with pIC50 of 6.1, 6.3, and 6.6, respectively. price>
R-C-738 erastin CAS No. 571203-78-6 Erastin is a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality in cells with H-Ras mutations. price>
R-R-2438 ARV-771 CAS No.1949837-12-0 ARV-771/CAS No.1949837-12-0 is a powerful BET degrader based on PROTAC technology with Kds of 34 nM, 4.7 nM, 8.3 nM, 7.6 nM, 9.6 nM and 7.6 nM for BRD2 (1) , BRD2 (2), BRD3 (1), BRD3 (2), BRD4 (1) and BRD4 (2), respectively. price>
R-C-739 SCH-772984 CAS No. 942183-80-4 SCH772984 is a novel,specific inhibitor of ERK1/2 with IC50 values of 4 nM and 1 nM in cell-free assay,respectively,And show robust efficacy in RAS-or BRAF-mutant cancer cells. price>
R-R-2439 dBET1 CAS No.1799711-21-9 dBET1/CAS No.1799711-21-9 is a PROTAC connected by ligands for Cereblon and BRD4 with an EC50 of 430 nM. dBET1 is a PROTAC that composes of (+)-JQ1 (HY-13030) linked to NSC 527179 (HY-14658) with a linker. price>
R-C-740 PF-3274167 cas:900510-03-4 Cligosiban (PF-3274167),a high oral bioavailability and good brain-penetrant non-peptide oxytocin receptor antagonist,shows a high-affinity(Ki=9.5 nM)and an excellent selectivity versus the vasopressin receptors with almost no affinity for the V1b and V1a subtypes.Cligosiban inhibits ejaculatory physiology in rodents. price>
R-R-2440 dCBP-1 CAS No.2484739-25-3 dCBP-1/CAS No.2484739-25-3 is a potent and selective heterobifunctional degrader of p300/CBP based on Cereblon ligand. dCBP-1 is exceptionally potent at killing multiple myeloma cells and ablates oncogenic enhancer activity driving MYC expression. price>
R-C-741 ISRIB CAS : 1597403-47-8 ISRIB is a potent and selective PERK inhibitor with IC50 of 5 nM. price>
R-R-2441 FHD-286 CAS No.2671128-05-3 FHD-286/CAS No.2671128-05-3 is a selective, oral inhibitor of SMARCA4/SMARCA2 ATPase (BRG1 and BRM) inhibitor. FHD-286 has the potential for the research of BAF (BRG1/BRM-associated factor)-related disorders such as acute myeloid leukemia. price>
R-C-742 USP7-USP47 cas:1247825-37-1 USP7/USP47 inhibitor is a selective ubiquitin-specific protease 7/47 (USP7/USP47) inhibitor,with EC50s of 0.42 μM and 1.0 μM,respectively. price>
R-R-2442 NSC 228155 CAS No.113104-25-9 NSC 228155/CAS No.113104-25-9 is an activator of EGFR, binds to the extracellular region of EGFR and enhances tyrosine phosphorylation of EGFR. NSC 228155 is also a potent inhibitor of KIX-KID interaction, inhibits the kinase-inducible domain (KID) of CREB and the KID-interacting domain (KIX) of CBP, with an IC50 of 0.36 μM. price>
R-C-743 GSK1838705A CAS:1116235-97-2 GSK1838705A is a small-molecule kinase inhibitor that inhibits IGF-IR and the insulin receptor with IC50s of 2.0 and 1.6 nmol/L,respectively. price>
R-R-2443 MG 149 CAS No.1243583-85-8 MG149 (Tip60 HAT inhibitor)/CAS No.1243583-85-8 is a selective and potent Tip60 inhibitor with IC50 of 74 uM, similar potentcy for MOF (IC50= 47 uM); little potent for PCAF and p300 (IC50 >200 uM). price>
R-C-744 AZD628 CAS No. : 942436-93-3 AZD-6280 is a selective GABAA(α2/3) receptor modulator,used for treatment of generalized anxiety disorder. price>
R-R-2444 Ziftomenib CAS No.2134675-36-6 Ziftomenib (KO-539)/CAS No.2134675-36-6 is an orally active menin-MLL interaction inhibitor with antitumor activities (WO2017161028A1, compound 151). price>
R-C-745 NVP-QAV-572 CAS:957209-68-6 NVP-QAV-572 is a potent PI3K kianse inhibitor with IC50 of 10 nM. price>
R-R-2445 GNE-781 CAS No.1936422-33-1 GNE-781/CAS No.1936422-33-1 is an orally active, highly potent and selective CBP inhibitor with an IC50 of 0.94 nM in TR-FRET assay. GNE-781 also inhibits BRET and BRD4(1) with IC50s of 6.2 nM and 5100 nM, respectively. GNE-781 displays antitumor activity in an MOLM-16 AML xenograft model. price>
R-C-746 LEE011 cas:1211441-98-3 Ribociclib(LEE01)is a highly specific CDK4/6inhibitor with IC50 values of 10 nM and 39 nM,respectively,and is over 1,000-fold less potent against the cyclin B/CDK1 complex. price>